Biochemical assays and deep cyclic inhibition in cancer treatment
Drug Target Review
JULY 12, 2023
Molecular-level biochemical assays like transcriptomics, genomics and proteomics have emerged as valuable tools for identifying potential targets in cancer treatment through deep cyclic inhibition (DCI). With this drop off, the goal is to reach a near-zero drug trough before the 24-hour mark.
98 
Let's personalize your content